Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

v3.23.3
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2023
Basis of Presentation and Summary of Significant Accounting Policies [Abstract]  
Schedule of Reconciliation of the Components of Cash and Restricted Cash The following table provides a reconciliation of the components of cash, cash equivalents and restricted cash reported in the Company’s condensed consolidated balance sheets to the total of the amount presented in the condensed consolidated statements of cash flows:
    September 30,  
(in thousands)   2023     2022  
Cash and cash equivalents   $ 21,593     $ 26,251  
Restricted cash     125       125  
Restricted cash – non-current     568       621  
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows   $ 22,286     $ 26,997  

 
Schedule of Deferred Revenue Changes in the deferred revenue account were as follows:
(in thousands)    Nine Months
Ended
September 30,
2023		     Year
Ended
December 31,
2022		  
Balance, beginning of period   $ 7,254     $ 6,238  
Deferral of revenue     33,907       31,949  
Recognition of unearned revenue     (33,168 )     (30,933 )
Balance, end of period   $ 7,993     $ 7,254  

 
Schedule of Diluted Weighted-Average Shares of Common Stock Outstanding The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding, as they would be anti-dilutive:
    September 30,
2023		     September 30,
2022		  
Common stock warrants     4,382,235       2,801,703  
Stock options     9,511,659       8,118,888  
Restricted stock units     196,688      
—
  
      14,090,582       10,920,591